← Back to headlines
Gilead Sciences and Lakefront Biotherapeutics Acquire Ouro Medicines
Gilead Sciences (GILD) and Lakefront Biotherapeutics have jointly acquired Ouro Medicines to further advance their pipeline of autoimmune treatments.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
